Logo image of AARD

AARDVARK THERAPEUTICS INC (AARD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:AARD - US0029421007 - Common Stock

13.225 USD
-0.24 (-1.78%)
Last: 12/30/2025, 8:04:25 PM
13.225 USD
0 (0%)
After Hours: 12/30/2025, 8:04:25 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AARD revenue by date.AARD revenue by date.
N/AN/AN/A
2,647.71%		N/A
685.06%		N/A
150.59%		N/A
70.56%		N/A
74.49%		N/A
37.89%
EBITDA
YoY % growth
AARD ebitda by date.AARD ebitda by date.
-10.253M-7.318M
28.63%		-22.769M
-211.14%		N/A
-170.22%		N/A
-38.86%		N/A
-39.52%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
AARD ebit by date.AARD ebit by date.
-10.363M-7.415M
28.45%		-22.785M
-207.28%		N/A
-179.63%		N/A
-38.72%		N/A
-35.50%		N/A
16.76%		N/A
60.31%		N/A
321.73%		N/A
186.84%		N/A
85.08%
Operating Margin
AARD operating margin by date.AARD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AARD eps by date.AARD eps by date.
N/AN/AN/AN/AN/A
-24.33%		N/A
-11.78%		N/A
46.21%		N/A
65.91%		N/A
276.67%		N/A
191.70%		N/A
87.97%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.85-0.92
-29.30%		-0.97
-46.43%		-0.90
-20.36%		-0.95
-10.68%		-1.24
-35.56%		-1.53
-58.31%		-1.95
-115.82%		-2.37
-150.13%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-19.448M
-105.80%		-19.503M
-86.28%		-20.723M
-30.76%		-20.935M
-18.26%		-22.251M
-14.41%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.75 -0.810.067.92%
Q2 2025
Q2Q % growth		 -0.66 -0.61-0.05-7.84%
Q1 2025
Q2Q % growth		 -0.71 -0.69-0.02-3.38%
AARD Yearly EPS VS EstimatesAARD Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
AARD Yearly Revenue VS EstimatesAARD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.83% -3.14% 0.29% -5.79%
RevenueN/A N/A N/A N/A